European Journal of Molecular & Clinical Medicine

Abstract

Background: To assess and contrast the effectiveness, hemodynamic stability, and side effects of dexmedetomidine and magnesium sulphate when used to reduce intraoperative shivering.
Methods: The study was conducted at Department of Anesthesiology at Government general hospital, Guntur, India from January 2021 to March 2022. The study was performed on 100 patients undergoing lower abdominal and lower limb surgeries under neuraxial anesthesia.
Result: In the magnesium sulphate group, it took an average of 3.88+0.25 mins for the shivering to stop, but in the dexmedetomidine group, it took an average of 2.18+0.26 mins. The shivering score of magnesium sulphate and dexmedetomidine was 3+0 mins. Magnesium sulphate was provided in one case, and no one in the dexmedetomidine group experienced shivering again.
Conclusion: Together, dexmedetomidine 1 mcg/kg and magnesium sulphate 50 mcg/kg significantly decreased intraoperative shivering. Dexmedetomidine stopped the shivering in the shortest length of time while simultaneously raising body warmth and maintaining reduced pulse and respiratory rates.